Published in J Cell Biol on February 01, 1983
Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J (1995) 1.84
The 46,000-dalton tyrosine protein kinase substrate is widespread, whereas the 36,000-dalton substrate is only expressed at high levels in certain rodent tissues. J Cell Biol (1984) 1.31
Isolation and characterization of glucocorticoid- and cyclic AMP-induced genes in T lymphocytes. Mol Cell Biol (1989) 1.31
Tissue-specific nuclear factors mediate expression of the CD3 delta gene during T cell development. EMBO J (1990) 1.20
Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures. Mol Cell Biol (1988) 1.15
Glucocorticoid regulation of murine leukemia virus transcription elements is specified by determinants within the viral enhancer region. J Virol (1987) 1.09
Evidence that glucocorticoid- and cyclic AMP-induced apoptotic pathways in lymphocytes share distal events. Mol Cell Biol (1992) 1.07
Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures. Mol Cell Biol (1989) 1.06
Negative trans-regulation of T-cell antigen receptor/T3 complex mRNA expression in murine T-lymphoma somatic cell hybrids. Proc Natl Acad Sci U S A (1986) 0.86
Evidence for trans regulation of apoptosis in intertypic somatic cell hybrids. Mol Cell Biol (1994) 0.78
Assignment of the human gene for the glucocorticoid receptor to chromosome 5. Proc Natl Acad Sci U S A (1985) 0.78
Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells. Cancer Cell Int (2014) 0.77
Glucocorticoid-mediated immunomodulation: hydrocortisone enhances immunosuppressive endogenous retroviral protein (p15E) expression in mouse immune cells. Clin Exp Immunol (1995) 0.75
SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS. Science (1964) 24.40
5-Methylcytosine in eukaryotic DNA. Science (1981) 8.85
Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell (1979) 6.47
Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells. J Biol Chem (1979) 6.31
Mouse myelomas and lymphomas in culture. Exp Cell Res (1970) 5.12
Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet (1976) 5.05
DNA methylation controls the inducibility of the mouse metallothionein-I gene lymphoid cells. Cell (1981) 3.67
Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol (1979) 3.32
Amplification of the metallothionein-I gene in cadmium-resistant mouse cells. Proc Natl Acad Sci U S A (1981) 3.11
Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo. Proc Natl Acad Sci U S A (1981) 2.63
Cell cycle analysis by flow cytometry. Methods Enzymol (1979) 2.18
Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line. J Immunol (1973) 2.14
Glucocorticoid regulation of metallothionein-I mRNA synthesis in cultured mouse cells. J Biol Chem (1981) 2.12
Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res (1977) 1.77
5-Azacytidine-induced reactivation of a herpes simplex thymidine kinase gene. Science (1982) 1.56
5-Azacytidine induction of mouse endogenous type C virus and suppression of DNA methylation. Proc Natl Acad Sci U S A (1981) 1.46
Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines. Int J Cancer (1981) 1.32
Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell (1977) 1.23
Adrenal corticosteroids enhance production of type-C virus induced by 5-iodo-2'-deoxyuridine from cultured mouse fibroblasts. Proc Natl Acad Sci U S A (1973) 1.23
General features of steroid resistance on lymphoid cell lines. Mol Cell Endocrinol (1978) 1.16
Genetic and biochemical studies with the adenosine analogs toyocamycin and tubercidin: mutation at the adenosine kinase locus in Chinese hamster cells. Somatic Cell Genet (1978) 1.08
Correlation between glucocorticoid receptor and cytolytic response of murine lymphoid cell lines. Cancer Res (1979) 1.04
Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7. Mol Cell Biol (1981) 1.01
Interaction of glucocorticoid receptors from lymphoid cell lines with their nuclear acceptor sites. Mol Cell Endocrinol (1978) 0.99
Mouse lymphoma cells: mechanisms of resistance to glucocorticoids. Monogr Endocrinol (1979) 0.94
Interactions of chemical inducers and steroid enhancers of endogenous mouse type-C RNA viruses. Virology (1975) 0.94
Characterization of a new type of thymoma variants supersensitive to dexamethasone. J Steroid Biochem (1981) 0.91
Analysis of steroid resistance in lymphoid cell hybrids. Somatic Cell Genet (1980) 0.86
Induction of glucocorticoid-resistant variants in a murine thymoma line by antitumor drugs. Cancer Res (1981) 0.83
Studies on the antiglucocorticoid action of progesterone in rat thymocytes: early in vitro effects. J Steroid Biochem (1979) 0.82
Effect of glucocorticoids on activation of leukemia virus in AKR mouse embryo cells. Cancer Res (1975) 0.78
Lac repressor-operator interaction. I. Equilibrium studies. J Mol Biol (1970) 13.32
The lac repressor-operator interaction. 3. Kinetic studies. J Mol Biol (1970) 10.07
DNA binding of the lac repressor. J Mol Biol (1968) 5.02
Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science (1984) 3.84
Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature (1985) 3.73
Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science (1988) 3.22
lac Repressor-operator interaction. VI. The natural inducer of the lac operon. J Mol Biol (1972) 3.06
On the assay, isolation and characterization of the lac repressor. J Mol Biol (1968) 2.94
Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med (1987) 2.69
"Second" and "third operator" of the lac operon: an investigation of their role in the regulatory mechanism. J Mol Biol (1979) 2.56
lac repressor--operator interaction. II. Effect of galactosides and other ligands. J Mol Biol (1970) 2.42
Molecular characterization of genome of a novel human T-cell leukaemia virus. Nature (1983) 2.36
Suppression of and complementation among mutants of the regulatory gene of the lactose operon of Escherichia coli. J Mol Biol (1965) 2.32
Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol (1986) 2.31
lac Repressor-operator interaction. IX. The binding of lac repressor to operators containing Oc mutations. J Mol Biol (1974) 2.31
A low-copy-number vector utilizing beta-galactosidase for the analysis of gene control elements. Gene (1987) 2.30
Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature (1985) 2.25
Cloning and analysis of the promotor region of the human fibronectin gene. Proc Natl Acad Sci U S A (1987) 2.10
Lac repressor-operator interaction. V. Characterization of super- and pseudo-wild-type repressors. J Mol Biol (1972) 2.02
Measurements of unwinding of lac operator by repressor. Nature (1974) 1.98
Ethiopia: between Sub-Saharan Africa and western Eurasia. Ann Hum Genet (2005) 1.98
Characterization of the human granulocyte-macrophage colony-stimulating factor promoter region by genetic analysis: correlation with DNase I footprinting. Mol Cell Biol (1988) 1.97
Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science (1986) 1.91
Localization of the gene encoding human erythroid-potentiating activity to chromosome region Xp11.1----Xp11.4. Am J Hum Genet (1986) 1.84
The lac repressor-operator interaction. VII. A repressor with unique binding properties: the X86 repressor. J Mol Biol (1972) 1.78
High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. Proc Natl Acad Sci U S A (1986) 1.76
Regulation of expression of human granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 1.76
The lac repressor-operator interaction. IV. Assay and purification of operator DNA. Biochem Biophys Res Commun (1970) 1.75
Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood (1986) 1.74
Studies of the putative transforming protein of the type I human T-cell leukemia virus. Science (1985) 1.65
Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood (1987) 1.63
Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. J Exp Med (1989) 1.62
The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q- anomaly. Science (1985) 1.61
Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor beta, and cAMP in human cell lines. J Cell Biol (1988) 1.61
Repressors. Adv Protein Chem (1976) 1.51
Biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor: effect on normal bone marrow and leukemia cell lines. Blood (1986) 1.51
Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol (1986) 1.46
FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol Cell Biol (1995) 1.45
A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med (1986) 1.44
Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts. Cell (1983) 1.42
Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis. J Immunol (1988) 1.41
Characterization of the human granulocyte-macrophage colony-stimulating factor receptor. J Biol Chem (1988) 1.35
Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res (2000) 1.32
Composite predictions of secondary structures of lac repressor. Biopolymers (1979) 1.31
Isolation and characterization of glucocorticoid- and cyclic AMP-induced genes in T lymphocytes. Mol Cell Biol (1989) 1.31
Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition. Biochem Biophys Res Commun (1997) 1.30
DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486. EMBO J (1984) 1.27
Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell (1977) 1.23
Demethylation and expression of murine mammary tumor proviruses in mouse thymoma cell lines. Proc Natl Acad Sci U S A (1983) 1.23
Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene (1989) 1.22
Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood (1990) 1.19
Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood (1989) 1.19
Forskolin inducibility and tissue-specific expression of the fibronectin promoter. Mol Cell Biol (1989) 1.19
General features of steroid resistance on lymphoid cell lines. Mol Cell Endocrinol (1978) 1.16
Analysis of the cya locus of Escherichia coli. Gene (1984) 1.16
Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line. Nature (1983) 1.16
Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc Natl Acad Sci U S A (1988) 1.15
Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter. Mol Cell Biol (1994) 1.14
Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity. J Biol Chem (1984) 1.11
Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cells. Mol Cell Biol (1989) 1.11
Lac repressor-operator interaction. 8. Lactose is an anti-inducer of the lac operon. J Mol Biol (1973) 1.07
The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro. Stem Cells (1999) 1.06
Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. Brain (1996) 1.06
Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors. Blood (1999) 1.05
Correlation between glucocorticoid receptor and cytolytic response of murine lymphoid cell lines. Cancer Res (1979) 1.04
Granulocyte-macrophage colony-stimulating factor modulates the excitation-response coupling sequence in human neutrophils. J Immunol (1988) 1.03
Genes newly identified as regulated by glucocorticoids in murine thymocytes. Mol Endocrinol (1991) 1.01
Notch signaling enhances survival and alters differentiation of 32D myeloblasts. J Immunol (2000) 1.00
Characterization of HOX gene expression during myelopoiesis: role of HOX A5 in lineage commitment and maturation. Blood (1999) 1.00
Interaction of glucocorticoid receptors from lymphoid cell lines with their nuclear acceptor sites. Mol Cell Endocrinol (1978) 0.99
Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function. J Biol Chem (1986) 0.99
Genetically engineered zinc-chelating adenylate kinase from Escherichia coli with enhanced thermal stability. J Biol Chem (1998) 0.98
Identification of novel functional regions important for the activity of HOXB7 in mammalian cells. J Immunol (2001) 0.97
Colony-stimulating factors and host defense. Ann Intern Med (1989) 0.96
Identification of a gene induced by glucocorticoids in murine T-cells: a potential G protein-coupled receptor. Mol Endocrinol (1991) 0.96
5' upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8. Oncogene (1991) 0.96
A new murine model system for the in vitro development of thymoma cell heterogeneity. Cancer Res (1984) 0.96
K562 cells produce and respond to human erythroid-potentiating activity. Blood (1988) 0.94
Characterization of the priming effects of human granulocyte-macrophage colony-stimulating factor on human neutrophil leukotriene synthesis. Prostaglandins (1988) 0.91
Characterization of a new type of thymoma variants supersensitive to dexamethasone. J Steroid Biochem (1981) 0.91
HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences. Oncogene (1992) 0.91
Defect states at the TiO2(110) surface probed by resonant photoelectron diffraction. Phys Rev Lett (2008) 0.90
Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire. Exp Hematol (1993) 0.90
Glucorticoid resistance in murine lymphoma and thymoma lines. Cancer Res (1978) 0.88
Two outbreaks of botulism associated with consumption of green olive paste, France, September 2011. Euro Surveill (2011) 0.88
The role of the homeobox gene, HOX B7, in human myelomonocytic differentiation. Blood (1995) 0.87
Characterization of the role of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit in the activation of JAK2 and STAT5. Blood (1998) 0.87
Isolation of pseudorevertants of lac oc mutants: selection system for superoperator mutations. J Bacteriol (1976) 0.87
Characterization of purified human erythroid-potentiating activity. Prog Clin Biol Res (1985) 0.86
Analysis of steroid resistance in lymphoid cell hybrids. Somatic Cell Genet (1980) 0.86
Cyclic AMP-dependent protein kinase modulation of the glucocorticoid-induced cytolytic response in murine T-lymphoma cells. Mol Endocrinol (1989) 0.86
Multiple mechanisms control the expression of granulocyte-macrophage colony-stimulating factor by human fibroblasts. J Immunol (1989) 0.86
Enhancement of neutrophil function by granulocyte-macrophage colony-stimulating factor involves recruitment of a less responsive subpopulation. Blood (1988) 0.86
Intrinsic nature of the excess electron distribution at the TiO2(110) surface. Phys Rev Lett (2012) 0.85
Relationship between human T cell leukemia virus-II and atypical hairy cell leukemia: a serologic study of hairy cell leukemia patients. Leukemia (1987) 0.85
Reversal of multidrug resistance by RU 486. Cancer Res (1994) 0.85
Steroidogenic activity of high molecular weight forms of corticotropin. Biochemistry (1979) 0.85